The prognosis of kidney cancer patients often cannot be determined until tumor samples are surgically removed and evaluated. Now, researchers have discovered that the lymphocyte count — which is routinely measured in laboratory tests — is a simple and effective prognostic indicator in patients with renal cell carcinoma.